SPI
16 210,86
|
53,04
|
0,33%
|
Analysen zu SPI-Werten
24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
24.04.25 | Roche Kaufen | DZ BANK | |
24.04.25 | Richemont Outperform | Bernstein Research | |
24.04.25 | Nestlé Neutral | UBS AG | |
24.04.25 | Nestlé Market-Perform | Bernstein Research | |
24.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
24.04.25 | Roche Buy | UBS AG | |
24.04.25 | Roche Outperform | Bernstein Research | |
24.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
24.04.25 | Nestlé Hold | Deutsche Bank AG | |
24.04.25 | Nestlé Add | Baader Bank | |
24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
24.04.25 | Nestlé Underperform | Jefferies & Company Inc. | |
24.04.25 | Roche Hold | Jefferies & Company Inc. | |
23.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
23.04.25 | ams-OSRAM Buy | UBS AG | |
22.04.25 | ABB Sector Perform | RBC Capital Markets | |
22.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
17.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
17.04.25 | Richemont Buy | Jefferies & Company Inc. | |
17.04.25 | Nestlé Add | Baader Bank | |
17.04.25 | ABB Underperform | Bernstein Research | |
17.04.25 | ABB Neutral | UBS AG | |
17.04.25 | ABB Hold | Jefferies & Company Inc. | |
17.04.25 | ABB Sector Perform | RBC Capital Markets | |
16.04.25 | DocMorris Reduce | Baader Bank | |
16.04.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
16.04.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
16.04.25 | Givaudan Neutral | UBS AG | |
15.04.25 | Givaudan Halten | DZ BANK | |
15.04.25 | DocMorris Hold | Deutsche Bank AG | |
15.04.25 | ABB Sector Perform | RBC Capital Markets | |
14.04.25 | DocMorris Hold | Warburg Research | |
14.04.25 | Roche Buy | UBS AG | |
14.04.25 | Richemont Buy | UBS AG | |
14.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
14.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
14.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
14.04.25 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
14.04.25 | Roche Underweight | JP Morgan Chase & Co. |